Guangdong Zhongsheng Pharmaceutical Hits Day High with 9.99% Surge

Guangdong Zhongsheng Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 9.99% on June 18, 2026. The stock reached an intraday high of CNY 22.90, showcasing its strong market activity. This performance stands in contrast to the China Shanghai Composite, which saw a decline of 0.43% on the same day. Over the past year, Guangdong Zhongsheng has delivered an impressive return of 52.06%, significantly outperforming the broader market's 20.71% gain. The company's financial metrics reflect a robust position within the pharmaceuticals and biotechnology sector, with a notable increase in net profit of 296.49% reported in its latest quarterly results. Additionally, the company has maintained positive results for four consecutive quarters, highlighting its operational stability. With a market capitalization of CNY 15,764 million, Guangdong Zhongsheng boasts a return on equity of 7.54% and a price-to-book ratio of 3.79. The stock's performance metrics indicate a strong market presence, further solidified by a high dividend yield of 1.08%.